Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 01/05/17 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 25/09/17 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 01/01/22 |
Corporate Officer/Principal | - | 01/01/17 | |
Corporate Officer/Principal | - | 16/11/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 17/12/19 |
Bruce Resnick
BRD | Director/Board Member | - | 17/12/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 38 944 971 | 36 835 813 ( 94,58 %) | 421 677 ( 1,083 %) | 94,58 % |
Coordinate società
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.com![Indirizzo Spark Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/20798561.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,73% | 123 Mrd | |
+21,13% | 115 Mrd | |
+22,07% | 25,85 Mrd | |
-17,94% | 20,9 Mrd | |
-16,50% | 16,52 Mrd | |
-11,76% | 16,77 Mrd | |
-44,45% | 15,56 Mrd | |
+69,92% | 15,49 Mrd | |
+1,41% | 13,45 Mrd |